• Geneticin G418: From Selection to Mechanistic Proof

  2026-08-18

  Geneticin and G418 Sulfate are more than routine selection reagents: they can help build stable, interpretable cell models when selection pressure is separated from biological causality. This guide connects ribosome-directed inhibition, engineered-cell workflows, antiviral testing, and mechanistic cancer assays.

• SR-202 (PPAR antagonist) for Reliable Cell Assays

  2026-08-18

  This scenario-based guide explains how SR-202 (PPAR antagonist), SKU B6929, can help researchers separate PPARγ-dependent biology from nonspecific viability or cytotoxicity effects. It combines product specifications, assay controls, protocol parameters, and pathway evidence relevant to adipogenesis, macrophage polarization, insulin resistance research, and metabolic disease models.

• A40926: From Biosynthetic Control to Translation

  2026-08-17

  A40926 is more than a glycopeptide antibiotic: it is a mechanistically defined research tool and the natural dalbavancin precursor. This thought-leadership guide connects bacterial cell wall inhibition, regulator cross-talk, assay design, manufacturing strategy, and translational decision-making for Gram-positive bacterial infection research.

• SCH772984: Selective ERK1/2 Inhibitor Guide

  2026-08-17

  SCH772984 is an ATP-competitive ERK1/2 inhibitor with reported nanomolar activity against ERK1 and ERK2. Its strongest evidence supports MAPK/ERK pathway inhibition in engineered cell and tumor models, while its potential relevance to radioresistant nasopharyngeal carcinoma remains a hypothesis rather than a validated application.

• WRN Loss, MSI, and p53/PUMA in Colon Cancer

  2026-08-16

  The 2022 PNAS study identifies p53 and PUMA-mediated apoptosis as the mechanism underlying the synthetic-lethal dependence of microsatellite-unstable colorectal cancer on Werner helicase. Its genetic, isogenic, and xenograft experiments clarify why p53 status is a major determinant of response and provide a framework for interpreting ML216-based RecQ helicase experiments.

• Alcian Blue & Nuclear Fast Red: Assay Logic

  2026-08-15

  The Alcian Blue & Nuclear Fast Red Staining Kit pH2.5 provides a chemically targeted readout of acid mucins and matrix-rich differentiation. This guide connects staining chemistry, assay controls, and biopsy-processing evidence to support more defensible histological decisions.

• Biotin-16-UTP for RNA Labeling Workflows

  2026-08-14

  Biotin-16-UTP provides a biotin-labeled uridine triphosphate for generating RNA that can be captured or detected through streptavidin or anti-biotin proteins. It is suited to in vitro transcription RNA labeling, RNA detection and purification, and RNA-protein interaction studies, but assay-specific incorporation efficiency and biological performance should be validated rather than assumed.

• VER 155008: HSP 70 Inhibitor Workflows

  2026-08-14

  Build mechanism-led cancer research workflows around VER 155008, from Hsp70 ATPase assays to apoptosis and colon carcinoma models. The same reagent also enables a carefully bounded investigation of HSC70-dependent viral internalization without implying that antiviral activity has been established.

• Ceruletide for Pancreatic Fibrosis Research

  2026-08-13

  Ceruletide, also known as Caerulein in experimental literature, enables controlled CCK-receptor stimulation for pancreatic injury, fibrosis, secretion, and motility workflows. This practical guide connects model induction with ORM2–ZG16 autophagy biology, assay design, formulation choices, and troubleshooting.

• FAM83A, Mitochondria, and White Adipocyte Differentiation

  2026-08-13

  The reference study identifies FAM83A as a regulator of white adipocyte differentiation that links casein kinase 1 activity with mitochondrial maintenance and lipogenesis. By delivering FAM83A-directed sgRNA/Cas9 to adipose tissue, the authors show that FAM83A loss reduces adipose expansion, disrupts mitochondrial function, and limits lipid droplet formation.

• Bay 11-7821 for NF-κB Inflammation Research

  2026-08-12

  Bay 11-7821 (BAY 11-7082) helps separate NF-κB-dependent cytokine production from upstream receptor signaling in infection and inflammation models. This practical guide translates recent CPSIT_0844–TLR2/TLR4 findings into assay workflows, controls, and troubleshooting strategies while extending the compound’s use to apoptosis and cancer research.

• Cardiogreen: From Vascular Signal to Immune Leverage

  2026-08-12

  Cardiogreen (Indocyanine Green) is more than a near-infrared vascular probe. Its protein-bound, intravascular behavior supports quantitative diagnostics, while its photochemical utility creates a translational bridge to cell-death biology and immune-enabled tumor therapy. This article interprets recent oral squamous cell carcinoma findings through a practical framework for assay design, evidence boundaries, and clinical translation.

• MMP-Responsive Hydrogel for Fibrous Dysplasia

  2026-08-11

  This preclinical study develops an injectable hyaluronic acid hydrogel containing triglycerol monostearate nanoparticles to deliver the RANKL inhibitor AS2676293 in response to lesion-associated matrix metalloproteinases. In a GNASR201C fibrous dysplasia mouse model, local treatment reduced lesion progression and improved bone microarchitecture, supporting a lesion-responsive alternative to sustained systemic RANKL inhibition.

• PX-478 2HCl: Designing Better HIF-1α Assays

  2026-08-11

  PX-478 2HCl is a versatile HIF-1α perturbation tool for linking hypoxia biology to measurable phenotypes. This guide focuses on model selection, temporal dosing, orthogonal readouts, and the practical lessons of a prenatal hypoxia study.

• ATS-9R for Adipocyte Gene Silencing

  2026-08-10

  ATS-9R enables targeted, non-viral nucleic-acid delivery to mature adipocytes and selected adipose-tissue populations through Prohibitin-mediated uptake. This practical guide covers complex formation, adipocyte screening, in vivo dosing logic, assay selection, and troubleshooting for obesity-associated inflammation and insulin resistance research.

15995 records 1/1067 page Next 12345 下5页 Last page